Brainscape's Knowledge GenomeTM


Top Flashcards (Certified)
All Flashcards

PR3151 Finals > IC17 CA- bacterial meningitits and C.difficile > Flashcards

IC17 CA- bacterial meningitits and C.difficile Flashcards

1
Q

define meningitis

A

inflammation of the leptomeninges

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

parts of leptomeninges

A
  • arachnoid
  • subarachnoid space (cerebrospinal fluid)
  • pia mater
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

causes of meningitis

A
  • infection (bacteria/septic meningitis, virus, fungal, parasitic, syphilis)
  • drugs (bactrim, ibuprofen)
  • autoimmune diseases
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

incidence of bacteria meningitis

A
  • more in africa population
  • male > female
  • common in children
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

RF bacteria meningitis

A
  • immune deficiency (CS, HIV)
  • prolonged close contact with infected pt
  • travel to endemic areas
  • head trauma
  • CNS shunts
  • neurologic pts
  • CSF fistula/leak
  • local infection (sinusitis, otitis media, pharyngitis)
  • splenectomised pt
  • congenital defects
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

how does bacteria gain entry into the body for meningitis

A
  1. invasion of mucosal surface -> hematogenous spread to brain
  2. spread from para-meningeal focus (otits media, sinusistis)
  3. penetrating head truama
  4. anatomical defects in meninges
  5. previous neurological procedures
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

symptoms of bacterial meningitis

A
  • fever, chills
  • classic triad (headache, neck rigidity, backache)
  • mental status changes (irritability)
  • photophobia
  • N/V, anorexia, poor feeding habits (infants)
  • Petechiae, purpura (wide and large red spots) -> from neisseria meningitidis meningitis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

physical signs of bacterial meningitis

A
  • Kernig sign (back pain when leg raised)
  • Brudzinski sign (neck raised, leg bent)
  • Bulging fontane (usually in babies)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

diagnosis of bacterial meningitis

A
  1. history and physical examination
  2. blood cultures
  3. lumbar puncture
    - elevated opening pressure
    - CSF composition
    - CSF gram-stain and culture
    - CSF PCR
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

normal CSF
- glucose
- protein
- WBC

A

glucose: 2.6–4.5 mmol/L
CSF : blood > 0.66

protein: <0.4 g/L
WBC: <5 cells/mm3

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

bacterial meningitis CSF
- glucose
- protein
- WBC

A

glucose: very low
CSF : blood > 0.4

protein: >1.5 g/L
WBC: >100 cells/mm3 (mostly neutrophils) -> pleocytosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

viral meningitis CSF
- glucose
- protein
- WBC

A

glucose: normal to slightly low
protein: normal to slightly raised
WBC: 5-1000 cells/mm3 (mostly lymphocytes)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

lab findings for bacterial meningitis

A

general lab findings (WBC, CRP, procalcitonin)
- signs of systemic infection
- non specific for bacterial meningitis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

radiology- brain imaging (CT/MRI) for meningitis

A
  • not required for diagnosis (usually only for differential diagnosis)
  • MAY BE DONE prior to lumbar puncture (prevent risk of brain herniation)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

meningitis: when should abx be started?

A

Antibiotic should be started as soon as possible (within 1 hour)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

bacterial meningitis likely organism in neonates (<1yo) and abx used

A
  • Grp B streptococcus (strep agalactiae)
  • E.coli
  • Listeria monocytogenes
  • IV ceftriaxone + ampicillin (for Listeria)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

bacterial meningitis likely organism in infants and children (1-23 mths) and abx used

A
  • Streptococcus pneumoniae
  • Neisseria meningitidis
  • Strep agalactiae
  • E.coli
  • IV ceftiaxone + vancomycin (vanco to cover resistant strep pneumoniae)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

bacterial meningitis likely organism children and adults (2-50 yo) and abx used

A
  • Strep pneumoniae
  • Neisseria meningitidis
  • IV ceftriaxone + vancomycin
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

bacterial meningitis likely organism adults (>50 yo) and abx used

A
  • Strep pneumoniae
  • Neisseria meningitidis
  • Listeria monocytogenes
  • gram negative bacilli (E.coli, Klebs)
  • IV ceftriaxone + vancomycin + ampicillin
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

culture directed for Strep pneumoniae

A

(pen susceptible) IV pen G, ampicillin
(pen resistant, cephalosporin susceptible) ceftriaxone
(pen, ceph resistant) vancomycin + rifampicin

duration: 10-14 days

IV rifampicin 300mg q12h

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

culture directed for Neisseria meningitidis

A

(pen susceptible) IV pen G, ampicillin
(pen resistant, mild allergy) ceftriaxone

duration: 5-7 days

22
Q

culture directed Listeria monocytogenes

A

(pen susceptible) IV pen G, ampicillin
(pen allergy) co-trimoxazole, meropenem

duration >21days

23
Q

culture directed Grp B strep (strep agalactiae)

A

(pen susceptible) IV pen G, ampicillin
(pen resistant, mild allergy) ceftriaxone

duration: 14-21 days

24
Q

if culture negative how? (Meningitis)

A

empiric abx for at least 14 days (may be extended)

25
bacterial meningitis - adjunctive corticosteroids
dexamethasone 10mg q6h (up to 4 days) For: > 6weeks (more than neonatal age) administer 10-20mins before or tgt with first dose abx stop when bacterial not (S.pneumoniae or H.influenzae) Benefits: - less hearing loss and neurologic sequelae (in H.influenzae and S.pneumoniae) - decreased mortality (in S.pneumoniae) Risks: - decrease abx penetration - ADR - mental status changes, hyperglycemia, HTN
26
bacterial meningitis - therapeutic response
- most pt improve within 48hrs - if never improve -> brain imaging is indicated to detect cerebrovascular complications (stroke, brain abscess) - if improve: no need repeat microbiological test - ADR - morbidity is common in bacterial meningitis
27
abx use in meningitis must:
1. distribute to CSF (achieve adequate CSF concentrations) - usually high dose, IV 2. active against likely pathogens 3. does not aggravate CNS morbidity (eg seizures) - imipenem and cefepime increase risk of seizures
28
meningitis: RF for close contact
exposure to oral secretions of pt with bacterial meningitidis
29
chemoprophylaxis for close contact for meningitis
1. rifampicin PO (adults) 600mg q12hr x4 doses (children) 10mg/kd q12hrs x4 doses (infants <1mth) 5mg/kg q12hrs x4 doses 2. ciprofloxacin 500mg PO x1 dose 3. ceftriaxone 125-250mg IM x1 dose
30
what kind of bacteria is Clostridoides difficile? - what are the toxins strains produced - how are spores transmitted?
gram positive, spore forming anaerobic bacillus - produces toxin A and B - transmitted by fecal-oral route
31
can C.difficle be asymptomatic?
yes asymptomatic carriage to fulminant disease
32
describe pathogenesis of C.difficile
- colonisation of intestinal C.difficle occurs via fecal-oral route - facilitated by abx use - toxigenic C.difficile release 2 toxins (toxin B more clinically important than toxin A) - toxin leads to inflammation and diarrhoea
33
why are some people asymptomatic carriers
they have antibodies to the toxins (more than normal)
34
C.difficile: RF
- advanced >65 yo - multiple/ severe comorbidities - immunosuppression - hx of CDI (more vulnerable) - GI surgery - tube feeding - prior hospitalisation (in last 1 year) - duration of hospitalisation - residence in nursing home or long term care facilities - use of abx - use of gastric acid suppressive tx (PPI)
35
which abx has increased risk of developing CDI
all abx greatest risk: - clindamycin - 3rd/4th gen cephalosporins - fluroquinolones highest risk while receiving abx, elevated up to 12 weeks later
36
which abx has protective effect against developing CDI
doxycycline tigecycline - inhibits toxin production - minimal effects on gut flora
37
CDI infection control and prevention
1. isolation 2. hand hygiene 3. environmental cleaning 4. antimicrobial stewardship
38
CDI: Recognise the critical role of Antimicrobial Stewardship in reducing incidence of CDI
protective effect with reduce use abx other modalities to reduce Cdiff - acid suppression (reduce unnecessary PPI) - probiotics (to reestablish microbiota)
39
Clinical presentations of C.difficile (mild, moderate, severe)
- watery diarrhoea (>= 3 loose stools in 24hrs) (mild) - diarrhoea, abdominal cramps (morderate) - fever, diarrhoea, nausea malaise - abdominal cramps and distension - leukocytosis - hypovolemia (due to dehydration) (severe) - fever, diarrhoea, diffused abdominal crmaps and distension - WBC >= 15 x 10^9 - SCr >= 133 umol/L (fulminant) - severe and sudden - hypotension/shock, ileus, megacolon (no peristalsis, colon is swollen)
40
dx of C.difficile
- presence of diarrhea (3 unformed stools in 24 hours), or - radiographic evidence of ileus or toxic megacolon AND - A positive stool test result for C difficile or its toxins, or - Colonoscopic or histopathologic evidence of pseudomembranous colitis
41
which grp of patients should CDI testing be done in?
symptomatic pt only lab stool test cannot differentiate btw colonisation and infection
42
things to note before doing stool test for C.difficile
- do not test for asymptomatic pt - only test when pt has diarrhoea (>= 3 unformed stools per day) - pt not using laxatives within past 48hrs - do not repeat in <7 days - do not repeat to document cure
43
management of C.difficile (tx principles)
- do not treat asymptomatic patients (confirm CDI presence) - discontinue any abx therapy not treating CDI (if possible) - select narrowest agent - avoid agents with strong association with CDI
44
define non severe C.difficile and abx used
WBC < 15 x 10^9 L AND SCr < 133 umol/L PO Fidaxomicin 200mg BD PO Vancomycin 125mg QDS (alternative) PO metronidazole 400mg TDS 10 days (14 days if sx not completely resolved)
45
define severe C.difficile and abx used
WBC >= 15 x 10^9 OR SCr >= 133 umol/L PO Fidaxomicin 200mg BD PO Vancomycin 125mg QDS 10 days (14 days if sx not completely resolved)
46
define fulminant C.difficile and abx used
hypotension OR ileus OR megacolon IV metronidazole 500mg q8h + PO vancomycin 500mg QDS +/- PR vancomycin 500mg QDS 10 days (14 days if sx not completely resolved)
47
if fixadomicin available in SG?
no
48
recurrent CDI definition
Defined as a resolution of CDI symptoms, followed by subsequent reappearance of symptoms after treatment has been discontinued
49
RF for recurrence in CDI
- administration of other antibiotics during or after initial treatment of CDI - a defective humoral immune response against C. difficile toxins - advanced age and - severe underlying disease - continued use of PPIs
50
tx for first recurrence of C.difficile
Initially using fidaxomicin/ vancomycin - PO fidaxomicin pulse - PO vancomycin tapered/pulse Initially using metronidazole - PO vancomycin 125mg QDS x10d
51
C.difficile monitoring
- sx should resolve in 10 days, if not extend for another 4 days - additional diagnostics/ escalation of meds if poor response - no evidence for decrease recurrence if use >10-14 days - do not continue C.difficile tx because pt needs to continue concurrent abx

PR3151 Finals (7 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2025 Bold Learning Solutions. Terms and Conditions